Header Logo

Connection

Meenakshi Jolly to Humans

Back to Details
This is a "connection" page, showing publications Meenakshi Jolly has written about Humans.
Meenakshi Jolly
Connection Strength
1.645
Humans
  1. Does higher quality of care in systemic lupus erythematosus translate to better patient outcomes? Lupus. 2023 May; 32(6):771-780.
    View in: PubMed
    Score: 0.048
  2. Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life? Arthritis Care Res (Hoboken). 2023 06; 75(6):1198-1205.
    View in: PubMed
    Score: 0.047
  3. Pneumococcal Vaccination Among Lupus Patients: Who Are the Recipients? J Clin Rheumatol. 2021 Dec 01; 27(8):e456-e461.
    View in: PubMed
    Score: 0.043
  4. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
    View in: PubMed
    Score: 0.042
  5. Patient-Reported Outcomes in Lupus. Rheum Dis Clin North Am. 2021 08; 47(3):351-378.
    View in: PubMed
    Score: 0.042
  6. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken). 2019 03; 71(3):406-412.
    View in: PubMed
    Score: 0.036
  7. Challenges to Practicing Rheumatology in an Academic Center. Rheum Dis Clin North Am. 2019 02; 45(1):27-37.
    View in: PubMed
    Score: 0.036
  8. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019 Feb; 28(2):163-173.
    View in: PubMed
    Score: 0.035
  9. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019 12; 71(12):1647-1652.
    View in: PubMed
    Score: 0.035
  10. Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? Arthritis Care Res (Hoboken). 2018 12; 70(12):1771-1777.
    View in: PubMed
    Score: 0.035
  11. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus. 2018 Apr; 27(5):728-737.
    View in: PubMed
    Score: 0.033
  12. Disease-specific quality of life in patients with lupus nephritis. Lupus. 2018 Feb; 27(2):257-264.
    View in: PubMed
    Score: 0.032
  13. Practice patterns in longitudinal lupus care provision: patient and physician perspectives. Lupus. 2017 Dec; 26(14):1556-1561.
    View in: PubMed
    Score: 0.032
  14. Systemic lupus erythematosus: The promise of PROMIS - is it ready for prime time in SLE? Nat Rev Rheumatol. 2017 08; 13(8):453-454.
    View in: PubMed
    Score: 0.032
  15. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index. Lupus. 2017 Apr; 26(4):396-402.
    View in: PubMed
    Score: 0.030
  16. Patient-reported outcomes in lupus clinical trials with biologics. Lupus. 2016 Sep; 25(10):1111-21.
    View in: PubMed
    Score: 0.030
  17. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016 06; 68(6):1422-31.
    View in: PubMed
    Score: 0.030
  18. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus. 2016 Jun; 25(7):735-40.
    View in: PubMed
    Score: 0.029
  19. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus. Lupus. 2015 Dec; 24(14):1486-91.
    View in: PubMed
    Score: 0.028
  20. Caregiving, dyadic quality of life and dyadic relationships in lupus. Lupus. 2015 Aug; 24(9):918-26.
    View in: PubMed
    Score: 0.027
  21. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Feb; 67(2):297-304.
    View in: PubMed
    Score: 0.027
  22. Health and quality of life outcomes. Health Qual Life Outcomes. 2014 Dec 12; 12:173.
    View in: PubMed
    Score: 0.027
  23. Body image intervention to improve health outcomes in lupus: a pilot study. J Clin Rheumatol. 2014 Dec; 20(8):403-10.
    View in: PubMed
    Score: 0.027
  24. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1542-50.
    View in: PubMed
    Score: 0.026
  25. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus. 2014 Dec; 23(14):1452-9.
    View in: PubMed
    Score: 0.026
  26. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus. Lupus. 2014 Aug; 23(9):881-8.
    View in: PubMed
    Score: 0.026
  27. Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep. 2013 Dec; 15(12):380.
    View in: PubMed
    Score: 0.025
  28. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013 Sep; 19(6):334-40.
    View in: PubMed
    Score: 0.025
  29. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol. 2014 Aug; 33(8):1079-84.
    View in: PubMed
    Score: 0.024
  30. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol. 2013 Aug; 40(8):1327-33.
    View in: PubMed
    Score: 0.024
  31. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus. 2013 Apr; 22(5):431-6.
    View in: PubMed
    Score: 0.024
  32. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus. 2013 Mar; 22(3):262-7.
    View in: PubMed
    Score: 0.024
  33. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures. J Am Acad Dermatol. 2013 Apr; 68(4):618-623.
    View in: PubMed
    Score: 0.023
  34. Rheumatologists' quality of care for lupus: comparison study between a university and county hospital. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1261-4.
    View in: PubMed
    Score: 0.023
  35. Body image in patients with systemic lupus erythematosus. Int J Behav Med. 2012 Jun; 19(2):157-64.
    View in: PubMed
    Score: 0.023
  36. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65.
    View in: PubMed
    Score: 0.022
  37. A brief assessment tool for body image in systemic lupus erythematosus. Body Image. 2012 Mar; 9(2):279-84.
    View in: PubMed
    Score: 0.022
  38. Treatment of lupus: impact on quality of life. Curr Rheumatol Rep. 2011 Aug; 13(4):324-37.
    View in: PubMed
    Score: 0.021
  39. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):891-8.
    View in: PubMed
    Score: 0.021
  40. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010 Sep; 37(9):1828-33.
    View in: PubMed
    Score: 0.020
  41. Pitfalls and opportunities in measuring patient outcomes in lupus. Curr Rheumatol Rep. 2010 Aug; 12(4):229-36.
    View in: PubMed
    Score: 0.020
  42. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol. 2010 Jun; 37(6):1150-7.
    View in: PubMed
    Score: 0.019
  43. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010 Jan; 69(1):29-33.
    View in: PubMed
    Score: 0.019
  44. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 Jun; 36(6):1209-16.
    View in: PubMed
    Score: 0.018
  45. Influence of an interactive joint model injection workshop on physicians' musculoskeletal procedural skills. J Rheumatol. 2007 Jul; 34(7):1576-9.
    View in: PubMed
    Score: 0.016
  46. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus. Arthritis Rheum. 2007 Mar 15; 57(2):352-4.
    View in: PubMed
    Score: 0.016
  47. Tattoo: inflicted vasculitis? J Clin Rheumatol. 2007 Feb; 13(1):49.
    View in: PubMed
    Score: 0.016
  48. Looking beyond the ordinary: genital lupus. Arthritis Rheum. 2006 Oct 15; 55(5):821-2.
    View in: PubMed
    Score: 0.015
  49. Hyperuricemia and associated diseases. Rheum Dis Clin North Am. 2006 May; 32(2):275-93, v-vi.
    View in: PubMed
    Score: 0.015
  50. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005 Sep; 32(9):1706-8.
    View in: PubMed
    Score: 0.014
  51. Discoid lupus erythematosus after tattoo: Koebner phenomenon. Arthritis Rheum. 2005 Aug 15; 53(4):627.
    View in: PubMed
    Score: 0.014
  52. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol. 2005 Aug; 11(4):213-5.
    View in: PubMed
    Score: 0.014
  53. The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al. Arthritis Rheum. 2005 Jun 15; 53(3):476.
    View in: PubMed
    Score: 0.014
  54. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004 Nov; 104(5 Pt 1):1105-6; author reply 1106.
    View in: PubMed
    Score: 0.013
  55. Chlamydial infection preceding the development of rheumatoid arthritis: a brief report. Clin Rheumatol. 2004 Oct; 23(5):453-5.
    View in: PubMed
    Score: 0.013
  56. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004; 13(1):64-9.
    View in: PubMed
    Score: 0.013
  57. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6.
    View in: PubMed
    Score: 0.013
  58. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1498-1507.
    View in: PubMed
    Score: 0.011
  59. Fatigue and its correlates in Indian patients with systemic lupus erythematosus. Clin Rheumatol. 2021 Mar; 40(3):905-911.
    View in: PubMed
    Score: 0.010
  60. Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Toward Improvement in Fatigue. Arthritis Care Res (Hoboken). 2020 10; 72(10):1440-1448.
    View in: PubMed
    Score: 0.010
  61. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients. Lupus. 2020 Nov; 29(13):1727-1735.
    View in: PubMed
    Score: 0.010
  62. Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study. Lupus. 2020 Nov; 29(13):1781-1789.
    View in: PubMed
    Score: 0.010
  63. Patient-Reported Outcomes Predict Mortality in Lupus. Arthritis Care Res (Hoboken). 2019 08; 71(8):1028-1035.
    View in: PubMed
    Score: 0.009
  64. Validation of SIMPLE Index for Lupus Disease Activity. J Clin Rheumatol. 2018 Sep; 24(6):313-318.
    View in: PubMed
    Score: 0.009
  65. Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus. Mol Med. 2018 06 01; 24(1):24.
    View in: PubMed
    Score: 0.009
  66. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017 06; 69(6):842-848.
    View in: PubMed
    Score: 0.008
  67. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283.
    View in: PubMed
    Score: 0.008
  68. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 2017 Aug; 26(9):967-974.
    View in: PubMed
    Score: 0.008
  69. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus. 2017 Jul; 26(8):849-856.
    View in: PubMed
    Score: 0.008
  70. Validation of the Lupus Impact Tracker in an Australian patient cohort. Lupus. 2017 Jan; 26(1):98-105.
    View in: PubMed
    Score: 0.008
  71. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol. 2014 Sep-Oct; 32(5 Suppl 85):S-85-95.
    View in: PubMed
    Score: 0.007
  72. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun. 2013 Dec; 14(8):471-8.
    View in: PubMed
    Score: 0.006
  73. Pain and depression predict self-reported fatigue/energy in lupus. Lupus. 2013 Jun; 22(7):684-9.
    View in: PubMed
    Score: 0.006
  74. Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus. Clin Dev Immunol. 2012; 2012:682018.
    View in: PubMed
    Score: 0.006
  75. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J Rheumatol. 2012 Jan; 39(1):73-8.
    View in: PubMed
    Score: 0.005
  76. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581.
    View in: PubMed
    Score: 0.005
  77. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011 Oct; 20(12):1285-92.
    View in: PubMed
    Score: 0.005
  78. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-a and serologic autoimmunity in lupus patients. J Immunol. 2011 Aug 01; 187(3):1298-303.
    View in: PubMed
    Score: 0.005
  79. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53.
    View in: PubMed
    Score: 0.005
  80. Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 2011 Jan; 20(1):80-4.
    View in: PubMed
    Score: 0.005
  81. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010 Aug; 12(4):237-49.
    View in: PubMed
    Score: 0.005
  82. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther. 2010; 12(4):R151.
    View in: PubMed
    Score: 0.005
  83. Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients. J Biomed Biotechnol. 2010; 2010:826434.
    View in: PubMed
    Score: 0.005
  84. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol. 2010 Jun 15; 184(12):7001-9.
    View in: PubMed
    Score: 0.005
  85. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010 Feb; 62(2):553-61.
    View in: PubMed
    Score: 0.005
  86. Patient reported outcomes and analgesia use in osteoarthritis of the knee. Osteoarthritis Cartilage. 2008 Nov; 16(11):1294-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.